VYNE Therapeutics Total Assets

VYNE Therapeutics (VYNE) currently reports a total assets of $26M as of March 2026. That compares with $56M in the prior-year period — down 54.1% year over year. Use the charts on this page to explore VYNE Therapeutics's total assets history and peer comparisons.

VYNE Therapeutics's total assets decreased from $56M to $26M — a 54.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

VYNE Therapeutics reported $26M in total assets as of March 2026. That compares with $56M in the prior-year period — down 54.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $26M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for VYNE Therapeutics, and consider following VYNE for alerts when major investors trade the stock.

VYNE Therapeutics is classified in the Healthcare sector. On total assets, it currently shows $26M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VYNE with unrelated industries.